Finance

Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal...

72-week data consistent with disease modification in IgAN, selected as a best-ranked abstract;Rapid and sustained improvements in hematuria over 36 weeks, with resolution...

Morgan Stanley’s top travel stocks this summer

Americans might be watching their spending amid persistent inflation, but it's not deterring many of them from traveling this summer — especially those...

US screens record 2.95 million airline passengers in single day By Reuters

By David Shepardson WASHINGTON (Reuters) -The U.S. Transportation Security Administration (TSA) said it screened 2.95 million airline passengers on Friday, the highest...

Neuralink competitor Precision Neuroscience testing human brain implant

Dr. Joshua Bederson places Precision Neuroscience's electrodes onto a brain.Ashley CapootAs the lights dimmed in an operating room at The Mount Sinai Hospital...

Israel presses on with strikes in Gaza after World Court ruling By Reuters

By Nidal al-Mughrabi CAIRO (Reuters) - Israeli forces killed more than 30 people in new attacks in the Gaza Strip, Palestinian medics...

Prosecutors ask judge in classified documents case to block Trump from statements endangering law enforcement

Former President Donald Trump looks on before the start of trial at the Manhattan Criminal Court during trial in New York City May...

Italian banks must quit Russia, ECB’s Panetta says By Reuters

STRESA, Italy (Reuters) - Italian banks must halt their business in Russia as staying in the country also brings a "reputational problem,"...

Digital health companies are launching programs around GLP-1s

Patent protection for Wegovy — Novo Nordisk's blockbuster weight loss drug, which contains the second generation GLP-1 active ingredient and is at least...

Wegovy users have less kidney-related health problems, analysis of Novo study finds By Reuters

By Maggie Fick LONDON (Reuters) - Novo Nordisk (NYSE:)'s Wegovy obesity drug reduced adverse kidney-related events by 22% in overweight and obese...
1...7,0427,0437,044...7,066Page 7,043 of 7,066

Latest articles

spot_imgspot_img